Stocks · Health care · Biological Products, (No Diagnostic Substances)

PRECISION BIOSCIENCES INC

DTIL Clue Score48
United States Fiscal year ends May CIK 0001357874 Results filed 3 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
J. Jefferson Smith
21 Jan 2026
Chief Research Officer
Sold after exercise
10,200
$4.03
$41.11K
Michael Amoroso
3 Nov 2025
President and CEO
Sold after exercise
3,409
$6.49
$22.12K
David S. Thomson
23 Jun 2021
Chief Operating Officer
Sold after exercise
30,000
$10.65
$319.50K
David S. Thomson
21 Jun 2021
Chief Operating Officer
Sold after exercise
15,000
$10.77
$161.55K
David S. Thomson
18 Jun 2021
Chief Operating Officer
Sold after exercise
10,000
$11.00
$110.00K
David S. Thomson
17 Jun 2021
Chief Operating Officer
Sold after exercise
10,000
$10.44
$104.40K
David S. Thomson
15 Jun 2021
Chief Operating Officer
Sold after exercise
2,858
$11.20
$32.01K
David S. Thomson
11 Jun 2021
Chief Operating Officer
Sold after exercise
30,000
$11.52
$345.60K
Derek Jantz
14 May 2021
Chief Scientific Officer
Sold after exercise
9,673
$9.17
$88.70K
Derek Jantz
13 May 2021
Chief Scientific Officer
Sold after exercise
9,673
$9.15
$88.51K
Matthew R. Kane
13 May 2021
President and CEO
Sold after exercise
9,675
$8.96
$86.69K
Derek Jantz
12 May 2021
Chief Scientific Officer
Sold after exercise
9,676
$8.72
$84.37K
Matthew R. Kane
10 May 2021
President and CEO
Sold after exercise
9,746
$8.25
$80.40K
Matthew R. Kane
7 May 2021
President and CEO
Sold after exercise
9,742
$8.57
$83.49K
Derek Jantz
19 Apr 2021
Chief Scientific Officer
Sold after exercise
9,676
$8.69
$84.08K
Derek Jantz
16 Apr 2021
Chief Scientific Officer
Sold after exercise
9,675
$8.84
$85.53K
Derek Jantz
15 Apr 2021
Chief Scientific Officer
Sold after exercise
9,676
$8.76
$84.76K
Matthew R. Kane
12 Apr 2021
President and CEO
Sold after exercise
9,741
$8.67
$84.45K
Matthew R. Kane
9 Apr 2021
President and CEO
Sold after exercise
9,737
$8.87
$86.37K
Matthew R. Kane
8 Apr 2021
President and CEO
Sold after exercise
9,736
$9.00
$87.62K
Derek Jantz
18 Mar 2021
Chief Scientific Officer
Sold after exercise
9,665
$11.08
$107.09K
Derek Jantz
17 Mar 2021
Chief Scientific Officer
Sold after exercise
9,665
$10.92
$105.54K
Derek Jantz
16 Mar 2021
Chief Scientific Officer
Sold after exercise
9,661
$11.97
$115.64K
Matthew R. Kane
12 Mar 2021
President and CEO
Sold after exercise
9,712
$11.36
$110.33K
Matthew R. Kane
11 Mar 2021
President and CEO
Sold after exercise
9,711
$11.38
$110.51K
Matthew R. Kane
10 Mar 2021
President and CEO
Sold after exercise
9,710
$11.79
$114.48K
Derek Jantz
22 Feb 2021
Chief Scientific Officer
Sold after exercise
9,660
$12.04
$116.31K
Derek Jantz
19 Feb 2021
Chief Scientific Officer
Sold after exercise
9,663
$11.55
$111.61K
Matthew R. Kane
18 Feb 2021
President and CEO
Sold after exercise
9,705
$12.23
$118.69K
Derek Jantz
18 Feb 2021
Chief Scientific Officer
Sold after exercise
6,871
$12.20
$83.83K
Matthew R. Kane
17 Feb 2021
President and CEO
Sold after exercise
9,705
$12.28
$119.18K
Matthew R. Kane
16 Feb 2021
President and CEO
Sold after exercise
9,697
$13.30
$128.97K
Derek Jantz
29 Jan 2021
Chief Scientific Officer
Sold after exercise
6,444
$12.25
$78.94K
Derek Jantz
28 Jan 2021
Chief Scientific Officer
Sold after exercise
6,444
$11.97
$77.13K
Derek Jantz
27 Jan 2021
Chief Scientific Officer
Sold after exercise
7,048
$11.68
$82.32K
Matthew R. Kane
26 Jan 2021
President and CEO
Sold after exercise
9,697
$13.37
$129.65K
Matthew R. Kane
25 Jan 2021
President and CEO
Sold after exercise
9,695
$13.74
$133.21K
Matthew R. Kane
22 Jan 2021
President and CEO
Sold after exercise
10,218
$13.53
$138.25K

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 38
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 11,715,028
Sales filed before the plan box existed 8
History held since 29 Mar 2019